Chargement en cours...
Optimal Systemic Treatment for Early Triple-Negative Breast Cancer
BACKGROUND: Approximately 10–15% of all breast tumors are triple-negative breast cancer (TNBC). TNBC have a higher risk of relapse and distant metastases compared to other subtypes. The optimal systemic management of TNBC according to national and international guidelines is discussed herein. SUMMAR...
Enregistré dans:
| Publié dans: | Breast Care (Basel) |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
S. Karger GmbH
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7383279/ https://ncbi.nlm.nih.gov/pubmed/32774215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000508759 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|